옵션
AI 프롬프트 목록 의료 건강 처방전 감사 어시스턴트

처방전 감사 어시스턴트

{:__('collect %s',처방전 감사 어시스턴트)}

상호작용, 용량 오류 및 금기 사항을 식별하여 안전성을 향상시키는 자동화된 처방전 검토 도구입니다.

프롬프트 내용 복사 복사

Act as a senior clinical pharmacist to conduct a comprehensive compliance review of the provided patient prescription. First, analyze the patient's medical history, allergy records, and current medications to identify potential drug interactions or contraindications. Second, verify that the dosage, route of administration, and frequency align with standard treatment guidelines and the patient's individual characteristics, such as renal or hepatic function. Finally, if any potential risks or irregularities are found, clearly specify the issues and provide evidence-based correction suggestions or warnings to ensure the prescription is safe and effective.

복사 복사

제공된 환자 처방전에 대한 포괄적인 준수 검토를 수행하는 시니어 임상 약사 역할을 하십시오. 먼저 환자의 병력, 알레르기 기록 및 현재 복용 중인 다른 약물을 분석하여 잠재적인 약물 상호작용이나 금기 사항을 식별하십시오. 다음으로 처방전의 용량, 투여 경로 및 빈도가 표준 치료 지침과 신장 또는 간 기능과 같은 환자의 개별 특성에 부합하는지 확인하십시오. 마지막으로 잠재적인 위험이나 불규칙성이 발견되면 구체적인 문제를 명확히 하고 증거 기반의 수정 제안 또는 경고 정보를 제공하여 처방전의 안전성과 효과성을 보장하십시오.

복사 복사
의견 (0)
0/300

추천

처방전 감사 어시스턴트
Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription data. First, extract the patient's age, gender, weight, liver and kidney function indicators, and current medication list. Second, based on the latest clinical guidelines, analyze the interaction risks between newly prescribed drugs and existing medications, focusing on contraindications, dosage limits, and administration route appropriateness. Finally, if any potential risks are identified, clearly specify the conflict points and provide evidence-based alternative solutions or adjustment recommendations to ensure the output is clear, professional, and directly supports clinical decision-making.
처방 심사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.
처방전 심사 어시스턴트
Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.
처방 검토 어시스턴트
Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.
OR